NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
Autors principals: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
American Society for Clinical Investigation
2023-05-01
|
Col·lecció: | The Journal of Clinical Investigation |
Accés en línia: | https://doi.org/10.1172/JCI171350 |